L&S Knock-Out ZEG/ DE000LX1LFS3 /
2024-11-12 8:10:33 AM | Chg.+0.43 | Bid9:50:08 PM | Ask9:50:08 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
1.61EUR | +36.44% | 1.39 Bid Size: 3,000 |
1.59 Ask Size: 3,000 |
Astrazeneca PLC ORD ... | 108.8175 - | 2078-12-31 | Call |
GlobeNewswire
08-12
Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune...
GlobeNewswire
08-08
Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets...
GlobeNewswire
06-26
As the PNH Market Continues to Crowd, Spherix Announces New Suite of Advisory Services to Explore Co...
GlobeNewswire
06-18
Mika Health Collaborates with AstraZeneca and Daiichi Sankyo to Deliver AI-Enabled Mobile Support to...
GlobeNewswire
06-18
Arch Biopartners Announces University of Calgary Ethics Approval to Proceed with Phase II Trial for ...
GlobeNewswire
06-13
Rheumatologists' Aggressive Approach to SLE Treatment Targets Specific Patient Types with Biologics
GlobeNewswire
05-08
Annual NMDP Gala in New York Raises More Than $560,000, Enabling More Patients to Receive Life-Savin...
GlobeNewswire
05-06
Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca